Free Account Opening + AMC Free Demat
Loading...

Chemcon IPO vs Gland Pharma IPO

Comparision between Chemcon IPO and Gland Pharma IPO.

IPO Details

Chemcon IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Chemcon IPO is up to ₹318.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Chemcon IPO is ₹340.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.

  Chemcon IPO Gland Pharma IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹338.00 per share ₹1,490.00 per share
Issue Price (Upper) ₹340.00 per share ₹1,500.00 per share
Issue Price (Final) ₹340.00 per share ₹1,500.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 44 shares 10 shares
Fresh Issue Size 48,52,940 shares 83,33,333 shares
Fresh Issue Size (Amount) up to ₹165.00 Cr up to ₹1,250.00 Cr
OFS Issue Size 45,00,000 shares 3,48,63,635 shares
OFS Issue Size (Amount) up to ₹153.00 Cr up to ₹5,229.55 Cr
Issue Size Total 93,52,940 shares 4,31,96,968 shares
Issue Size Total (Amount) up to ₹318.00 Cr up to ₹6,479.55 Cr

IPO Timetable

Chemcon IPO opens on Sep 21, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Chemcon IPO and Gland Pharma IPO is Sep 23, 2020, and Nov 11, 2020, respectively.

  Chemcon IPO Gland Pharma IPO
Anchor Bid Date
Issue Open Sep 21, 2020 Nov 09, 2020
Issue Close Sep 23, 2020 Nov 11, 2020
Basis Of Allotment (Tentative) Sep 28, 2020 Nov 17, 2020
Initiation of Refunds (Tentative) Sep 29, 2020 Nov 18, 2020
Credit of Share (Tentative) Sep 30, 2020 Nov 19, 2020
Listing date (Tentative) Oct 01, 2020 Nov 20, 2020
Anchor Lockin End date 1 Oct 28, 2020 Dec 17, 2020
Anchor Lockin End date 2 Dec 27, 2020 Feb 15, 2021

Financials

Chemcon IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .

  Chemcon IPO Gland Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
31-Mar-20 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 2,257.92 1,730.33 970.66 626.80
Total Revenue 2,660.17 3,053.26 1,583.91 899.96
Profit After Tax 488.53 430.41 263.81 28.24
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Promoter Shareholding (Pre-Issue) 100% 74%
Promoter Shareholding (Post-Issue) 74.47% 58%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Chemcon IPO retail investors (RII) are offered 32,83,580 shares while in Gland Pharma IPO retail investors are offered 32,83,580 shares. Qualified institutional buyers (QIB) are offered 18,68,344 shares in Chemcon IPO and 86,39,394 shares in Gland Pharma IPO.

  Chemcon IPO Gland Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 18,68,344 shares 86,39,394 shares
NII 14,07,249 shares 64,79,546 shares
RII 32,83,580 shares 1,51,18,939 shares
Employee 0 shares 0 shares
Others
Total 65,59,173 shares 3,02,37,879 shares

Bids Received (Subscription)

Chemcon IPO subscribed 149.30x in total, whereas Gland Pharma IPO subscribed 2.06x.

  Chemcon IPO Gland Pharma IPO
QIB (times) 113.54x 6.40x
NII (times) 449.14x 0.51x
Big NII (times)
Small NII (times)
RII (times) 41.15x 0.24x
Employee (times)
Other (times)
Total (times) 149.30x 2.06x

Comments

Add a public comment...